AR002993A1 - Una formulación farmaceutica pediatrica en la forma de un polvo seco o en forma de granulado la cual esta adaptada para su reconstirución con agua u otro medio acoso, de amoxicilina y acido clavulanico. - Google Patents

Una formulación farmaceutica pediatrica en la forma de un polvo seco o en forma de granulado la cual esta adaptada para su reconstirución con agua u otro medio acoso, de amoxicilina y acido clavulanico.

Info

Publication number
AR002993A1
AR002993A1 ARP960102435A AR10243596A AR002993A1 AR 002993 A1 AR002993 A1 AR 002993A1 AR P960102435 A ARP960102435 A AR P960102435A AR 10243596 A AR10243596 A AR 10243596A AR 002993 A1 AR002993 A1 AR 002993A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical formulation
harassment
amoxicillin
granulate
reconstitution
Prior art date
Application number
ARP960102435A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR002993(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9508989.2A external-priority patent/GB9508989D0/en
Priority claimed from GBGB9523655.0A external-priority patent/GB9523655D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR002993A1 publication Critical patent/AR002993A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención está dirigida al uso de una combinación del antibiótico amoxicilina trihidrato y del inhibidor de la beta-lactamasa clavulanatopotásico, en una relación de peso comprendida entre 6:1 y 8:1, en la preparación de unaform ulación farmacéutica para el tratamiento de infeccionesbacterianas en pacientes pediátricos. La invención también se refiere a las formulaciones farmacéuticas preparadas con dicha combinación y al método depreparación de las mismas.
ARP960102435A 1995-05-03 1996-05-03 Una formulación farmaceutica pediatrica en la forma de un polvo seco o en forma de granulado la cual esta adaptada para su reconstirución con agua u otro medio acoso, de amoxicilina y acido clavulanico. AR002993A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9508989.2A GB9508989D0 (en) 1995-05-03 1995-05-03 Pharmaceutical formulations
GBGB9523655.0A GB9523655D0 (en) 1995-11-18 1995-11-18 Method of treatment

Publications (1)

Publication Number Publication Date
AR002993A1 true AR002993A1 (es) 1998-05-27

Family

ID=26306975

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102435A AR002993A1 (es) 1995-05-03 1996-05-03 Una formulación farmaceutica pediatrica en la forma de un polvo seco o en forma de granulado la cual esta adaptada para su reconstirución con agua u otro medio acoso, de amoxicilina y acido clavulanico.

Country Status (33)

Country Link
EP (2) EP1013274A3 (es)
JP (1) JP3480939B2 (es)
KR (2) KR20050084498A (es)
CN (1) CN1104240C (es)
AP (1) AP851A (es)
AR (1) AR002993A1 (es)
AT (2) ATE206051T1 (es)
AU (1) AU712269C (es)
BG (2) BG64271B1 (es)
BR (1) BR9608270A (es)
CZ (1) CZ294434B6 (es)
DE (1) DE69615551T2 (es)
DK (1) DK0825860T3 (es)
DZ (1) DZ2028A1 (es)
EA (1) EA001878B1 (es)
ES (1) ES2160821T3 (es)
GR (1) GR3036722T3 (es)
HK (1) HK1009101A1 (es)
HU (2) HU0201920D0 (es)
IL (1) IL118091A (es)
MA (1) MA24339A1 (es)
MY (1) MY127622A (es)
NO (1) NO975037D0 (es)
NZ (1) NZ308478A (es)
OA (1) OA10533A (es)
PE (1) PE20011100A1 (es)
PL (1) PL323103A1 (es)
PT (1) PT825860E (es)
RO (1) RO116343B1 (es)
SK (1) SK283794B6 (es)
TR (1) TR199701294T1 (es)
UA (1) UA46763C2 (es)
WO (1) WO1996034605A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009042A1 (en) 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
CN100391456C (zh) * 2005-04-30 2008-06-04 南京师范大学 β-环糊精/阿莫西林包合物及其与克拉维酸钾的组合物及制备方法
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN101406450B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方阿莫西林油混悬注射液制备工艺
BR112014016850A8 (pt) * 2012-01-10 2017-07-04 Hoberman Alejandro composição líquida para o tratamento de otite media pediátrica, suspensão oral pediátrica, método de tratamento de otite média pediátrica em pacientes com menos de 24 meses de idade e método de tratamento de haemophilus influenzae, e moraxella catarrhalis produtoras de beta-lactamase em pacientes pediátricos com menos de 24 meses de idade
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
CN106474122B (zh) * 2016-09-07 2020-04-14 湘北威尔曼制药股份有限公司 一种阿莫西林克拉维酸钾的药物组合物及其应用
CN108403676B (zh) * 2018-03-20 2020-08-21 中山大学 琥珀酸在提高细菌对抗生素敏感性方面的应用
CN116327760A (zh) * 2022-12-26 2023-06-27 南京臣功制药股份有限公司 一种阿莫西林克拉维酸钾缓释干混悬剂及其制备方法
CN117379378A (zh) * 2023-12-07 2024-01-12 山东金瑞生物科技有限公司 一种兽用复方阿莫西林可溶性粉及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
US4337887A (en) 1979-09-18 1982-07-06 Weyerhaeuser Company Reinforced half slotted container
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
IL118091A0 (en) 1996-09-12
HUP9801064A3 (en) 1998-11-30
AU712269B2 (en) 1999-11-04
CZ345997A3 (cs) 1998-03-18
KR20050084498A (ko) 2005-08-26
CN1189100A (zh) 1998-07-29
EA001878B1 (ru) 2001-10-22
SK146297A3 (en) 1998-05-06
HUP9801064A2 (hu) 1998-08-28
DE69615551D1 (de) 2001-10-31
ATE206051T1 (de) 2001-10-15
RO116343B1 (ro) 2001-01-30
DK0825860T3 (da) 2001-11-19
NO975037L (no) 1997-10-31
AT4423U1 (de) 2001-07-25
BG64270B1 (bg) 2004-08-31
BG64271B1 (bg) 2004-08-31
CN1104240C (zh) 2003-04-02
BR9608270A (pt) 1999-05-04
AP851A (en) 2000-06-15
OA10533A (en) 2002-04-29
PT825860E (pt) 2002-01-30
JPH11504911A (ja) 1999-05-11
DZ2028A1 (fr) 2002-10-23
CZ294434B6 (cs) 2005-01-12
HK1009101A1 (en) 1999-05-28
EP1013274A2 (en) 2000-06-28
EP0825860A1 (en) 1998-03-04
MY127622A (en) 2006-12-29
NZ308478A (en) 1999-04-29
DE69615551T2 (de) 2002-04-25
NO975037D0 (no) 1997-10-31
WO1996034605A1 (en) 1996-11-07
GR3036722T3 (en) 2001-12-31
AU5814096A (en) 1996-11-21
EP1013274A3 (en) 2000-07-05
MA24339A1 (fr) 1998-07-01
PE20011100A1 (es) 2002-01-06
BG102024A (en) 1998-07-31
HU0201920D0 (es) 2002-08-28
SK283794B6 (sk) 2004-01-08
EA199700354A1 (ru) 1998-04-30
IL118091A (en) 2004-07-25
EP0825860B1 (en) 2001-09-26
AU712269C (en) 2002-06-06
PL323103A1 (en) 1998-03-16
UA46763C2 (uk) 2002-06-17
AP9701122A0 (en) 1997-10-31
ES2160821T3 (es) 2001-11-16
KR19990008253A (ko) 1999-01-25
BG106763A (en) 2004-05-31
JP3480939B2 (ja) 2003-12-22
TR199701294T1 (xx) 1998-04-21

Similar Documents

Publication Publication Date Title
AR002993A1 (es) Una formulación farmaceutica pediatrica en la forma de un polvo seco o en forma de granulado la cual esta adaptada para su reconstirución con agua u otro medio acoso, de amoxicilina y acido clavulanico.
AU4882597A (en) Pharmaceutical preparations for the controlled release of beta-lactam antibiotics
IT1177152B (it) Procedimento e composizione per la preparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale
EP1243267A3 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
HUP9901437A2 (hu) Gyógyszerkészítmény, mely amoxicillint és klavulánsavat tartalmaz
AU4022697A (en) Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
AR005642A1 (es) Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
ITRM920900A0 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
DK254588D0 (da) Antibiotika
AU5739499A (en) Pharmaceutical formulation of sodium amoxycillin and potassium clavulanate
CO5640085A2 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
ITMI922296A0 (it) Procedimento per la preparazione di antibiotici beta-lattamici sterili
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
IL82767A0 (en) Pharmaceutical formulation comprising a cephem and a penem derivative for the treatment of bacterial infections
BR9909726A (pt) Agente antimicrobiano, kit com o mesmo e seu uso
ECSP961736A (es) Metodo de tratamiento
AU560185B2 (en) Penicillin derivatives
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
ITMI931049A0 (it) Composizione farmaceutica mucoadesiva a rilascio controllato per la somministrazione orale di furosemide
TH22936B (th) สารผสมตามสูตรทางเภสัชกรรม
CA2220103A1 (en) Composition comprising amoxycillin and clavulanic acid
ITNA920032A0 (it) Utilizzo di cemento nella preparazione di idropitture per la edilizia formulazioni e procedimenti produttivi
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
FC Refusal